These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 31186275)
41. Plasma Epstein Barr viral load in adult-onset Hodgkin lymphoma in South India. Sinha M; Rao CR; Shafiulla M; Shankaranand B; Viveka BK; Lakshmaiah KC; Jacob LA; Babu GK; Jayshree RS Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):8-13. PubMed ID: 26657995 [TBL] [Abstract][Full Text] [Related]
42. The ecology and pathology of Epstein-Barr virus. Schmidt CW; Misko IS Immunol Cell Biol; 1995 Dec; 73(6):489-504. PubMed ID: 8713470 [TBL] [Abstract][Full Text] [Related]
43. The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma. Jones K; Wockner L; Brennan RM; Keane C; Chattopadhyay PK; Roederer M; Price DA; Cole DK; Hassan B; Beck K; Gottlieb D; Ritchie DS; Seymour JF; Vari F; Crooks P; Burrows SR; Gandhi MK Clin Exp Immunol; 2016 Feb; 183(2):206-20. PubMed ID: 26422112 [TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study. Elsayed AA; Asano N; Ohshima K; Izutsu K; Kinoshita T; Nakamura S Pathol Int; 2014 Jul; 64(7):336-45. PubMed ID: 25047504 [TBL] [Abstract][Full Text] [Related]
45. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study. Westmoreland KD; Stanley CC; Montgomery ND; Kaimila B; Kasonkanji E; El-Mallawany NK; Wasswa P; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Chikasema M; Makwakwa V; Kampani C; Dhungel BM; Sanders MK; Krysiak R; Tomoka T; Liomba NG; Dittmer DP; Fedoriw Y; Gopal S Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27781380 [TBL] [Abstract][Full Text] [Related]
46. Impact of Epstein-Barr virus in the clinical evolution of patients with classical Hodgkin's lymphoma in Brazil. Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Assis MG; Eiras DP; Dobo C; Oliveira JS Hematol Oncol; 2010 Sep; 28(3):137-41. PubMed ID: 20128016 [TBL] [Abstract][Full Text] [Related]
47. Composite lymphoma of nodular lymphocyte-predominant and classical Hodgkin lymphoma-Epstein-Barr virus association suggests divergent pathogenesis despite clonal relatedness. Szczepanowski M; Masqué-Soler N; Oschlies I; Schmidt W; Lück A; Klapper W Hum Pathol; 2013 Jul; 44(7):1434-9. PubMed ID: 23427872 [TBL] [Abstract][Full Text] [Related]
48. Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors. Hui KF; Tam KP; Chiang AKS Viruses; 2017 Nov; 9(11):. PubMed ID: 29160853 [TBL] [Abstract][Full Text] [Related]
49. A fulminant case of classical Hodgkin lymphoma: A diagnostic dilemma of Epstein-Barr virus-positive large B-cell neoplasms. Ichimata S; Kobayashi M; Ohya M; Otsuki T; Yanagisawa K; Tateishi K; Kato A; Matsuo A; Kanno H Pathol Int; 2019 Jul; 69(7):407-413. PubMed ID: 31215109 [TBL] [Abstract][Full Text] [Related]
50. Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells. Baumforth KR; Flavell JR; Reynolds GM; Davies G; Pettit TR; Wei W; Morgan S; Stankovic T; Kishi Y; Arai H; Nowakova M; Pratt G; Aoki J; Wakelam MJ; Young LS; Murray PG Blood; 2005 Sep; 106(6):2138-46. PubMed ID: 15933052 [TBL] [Abstract][Full Text] [Related]
51. Frequency of epstein-barr virus in classical hodgkin Lymphoma. Azhar M; Din HU; Muhammad I; Hashmi SN; Akhtar F J Ayub Med Coll Abbottabad; 2016; 28(2):271-275. PubMed ID: 28718560 [TBL] [Abstract][Full Text] [Related]
52. Current Trends and Alternative Scenarios in EBV Research. Minarovits J; Niller HH Methods Mol Biol; 2017; 1532():1-32. PubMed ID: 27873264 [TBL] [Abstract][Full Text] [Related]
53. Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era. Lupo J; Germi R; Lancar R; Algarte-Genin M; Hendel-Chavez H; Taoufik Y; Mounier N; Partisani M; Bonnet F; Meyohas MC; Marchou B; Semanova T; Prevot S; Costagliola D; Morand P; Besson C AIDS; 2019 May; 33(6):993-1000. PubMed ID: 30946153 [TBL] [Abstract][Full Text] [Related]
54. Epstein-Barr virus in the germinal centres of adenopathies affected by classic Hodgkin lymphoma. Martín P; Gomez-Lozano N; Montes S; Salas C; Provencio M; Bellas C Histopathology; 2011 Aug; 59(2):349-52. PubMed ID: 21884218 [No Abstract] [Full Text] [Related]
55. Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells. Di Napoli A; Al-Jadiri MF; Talerico C; Duranti E; Pilozzi E; Trivedi P; Anastasiadou E; Alsaadawi AR; Al-Darraji AF; Al-Hadad SA; Testi AM; Uccini S; Ruco L Pediatr Blood Cancer; 2013 Dec; 60(12):2068-72. PubMed ID: 24000236 [TBL] [Abstract][Full Text] [Related]
57. Immunotherapy for Epstein-Barr virus-associated cancers in children. Straathof KC; Bollard CM; Rooney CM; Heslop HE Oncologist; 2003; 8(1):83-98. PubMed ID: 12604735 [TBL] [Abstract][Full Text] [Related]
58. M1-like macrophage polarization prevails in young children with classic Hodgkin Lymphoma from Argentina. Jimenez O; Barros MH; De Matteo E; Garcia Lombardi M; Preciado MV; Niedobitek G; Chabay P Sci Rep; 2019 Sep; 9(1):12687. PubMed ID: 31481738 [TBL] [Abstract][Full Text] [Related]
59. Epstein-Barr virus in biopsies from patients with Hodgkin and non-Hodgkin lymphoma at the University of Puerto Rico immunohistochemistry laboratory. Córdova Pérez FJ; González-Keelan CI; Vélez R P R Health Sci J; 2003 Jun; 22(2):125-9. PubMed ID: 12866135 [TBL] [Abstract][Full Text] [Related]
60. [Correlation of Epstein-Barr virus infection and childhood lymphoma]. Xie ZD; Wang L; Lu D; Zhou CJ; Shen KL Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):365-7. PubMed ID: 18953837 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]